Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Federal Trade Commission
McKesson
Chubb
Queensland Health
UBS
Fuji
Cipla
US Department of Justice
Farmers Insurance

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018778

« Back to Dashboard

NDA 018778 describes NOVOLIN R, which is a drug marketed by Novo Nordisk Inc and is included in two NDAs. It is available from three suppliers. Additional details are available on the NOVOLIN R profile page.

The generic ingredient in NOVOLIN R is insulin recombinant human. There are thirty-nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the insulin recombinant human profile page.
Summary for 018778
Tradename:NOVOLIN R
Applicant:Novo Nordisk Inc
Ingredient:insulin recombinant purified human
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:Aug 30, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
QuintilesIMS
Merck
Medtronic
Colorcon
Dow
Federal Trade Commission
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot